Fackson Mwale PhD, FIOR


Current Appointment 

Graduate Program Director, Experimental Surgery
Professor of Surgery, McGill University
Fellow of International Orthopaedic Research (FIOR)
Co-Director of Clinical Innovation
Course director of non thesis
Course director of Medical Technology Internship
Senior Investigator, Lady Davis Institute

Clinical Interests:

Intervertebral Discs, Cartilage & Bone

Research Interests:

Tissue Engineering of Intervertebral Disc & Cartilage

Medical School:

Not Applicable

Residency Training:

Not Applicable

Education:

PhD
University of South Carolina
Columbia, South Carolina, USA
4 Years

Fellowship Training :

Post-Doctoral Research Fellowship
McGill University
Montreal, Quebec, Canada
3 Years

Research Associate
McGill University
Montreal, Quebec, Canada
3 Years

Current Address:

Lady Davies Institute
Jewish General Hospital
3755 Cote-St. Catherine Road, Room 602
Montréal, Québec
H3T 1E2
Tel: 514-340-8222, ext. 2948

E-mail:

fackson.mwale [at] mcgill.ca

 

Dr. Fackson Mwale is a tenured professor and Graduate Program Director in Experimental Surgery. He serves as co-director for the Surgical Innovation Concentration, a senior investigator at the Lady Davis Institute, past president of the Canadian Orthopaedic Research Society (CORS), Co-Founder of Trepso Therapeutics and Intervertech. He is the director of the non-thesis master’s degree and Medical Technology Internship I and II. He is also a course instructor for Surgical Innovation I and II.

He has made contributions to the fields of extracellular matrix biology, osteoarthritis, Spine biology and Tissue engineering. These contributions have earned him international recognition and acclaim. Dr. Mwale has been the Co-Director of the Orthopaedic Research Laboratory at Lady Davis Research Institute (McGill University affiliate) since 2000.

Dr. Mwale received his PhD from the University of South Carolina, followed by a post-Doctoral fellowship at McGill University with Dr. Robin Poole who was recently appointed to the Order of Canada. Dr. Mwale has been an invited speaker at more than 60 institutions in Canada and abroad. In 2010, he was the Canadian representative at the 7th Combined Orthopaedic Research Societies Meeting in Kyoto, Japan.

He has an outstanding record of service and academic leadership. He is a standing member of NIH’s Musculoskeletal Tissue Engineering (MTE) Study Section for a six-year term after completing a five-year term as a standing member of the NIH Skeletal Biology Structure and Regeneration (SBSR) Study Section. He is an editorial board member for European Cells and Materials since 2017 and Journal of Orthopedic Research since 2010, as well as a reviewer for many other journals. Additionally, he served as President of the Canadian Orthopaedic Research Society (2018-2019) and President of Canadian Connective Tissue Society (2012-14). Since 2007, he has been an organizing member of the Combined Orthopaedic Research Society, co-organizing the 2019 meeting in Montreal.

Dr. Mwale has a career total of more than 110 peer-reviewed papers. He has also presented more than 420 conference abstracts and delivered more than 90 invited talks including as national and international visiting professor. Dr. Mwale’s research has been well funded with grants from CIHR, NSERC, AO Foundation, CHRP, the North American Spine Society (NASS) and has been a co-applicant on NIH grants.

He was one of the invited scientists to NIAMS in Washington to a round table with other experts in the field to discuss the future of spine research. Dr. Mwale was recognized with the honorary status of Fellow of International Orthopaedic Research (FIOR) of the ICORS International College of Fellows. His other honors include the ORS young investigator award, the Berton Rahn Prize Award, the Hansjörg Wyss Award, the North American Spine Society Award, the Founders medal and the North American Spine Society (NASS) Award. Dr Mwale developed PrimeGrowthTM Media system for the long-term culture of whole discs with vertebrae, PrimeGrowthTM disc cell medium and PrimeStemTM an optimized stem cell media which are sold by Wisent Bioproducts.

 

 

 

Follow us on:

Back to top